AssetMark Inc’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

AssetMark Inc’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-13	Closed	–	–	1612
2018 Q4	$0	Hold	13	–	–	﹤0.01%	1623
2018 Q3	$0	Hold	13	–	–	﹤0.01%	1516
2018 Q2	$0	Hold	13	–	–	﹤0.01%	1520
2018 Q1	$0	Hold	13	–	–	﹤0.01%	2302
2017 Q4	$0	Hold	13	–	–	﹤0.01%	2315
2017 Q3	$0	Hold	13	–	–	﹤0.01%	1711
2017 Q2	$0	Hold	13	–	–	﹤0.01%	1568
2017 Q1	$0	Hold	13	–	–	﹤0.01%	1553
2016 Q4	$0	Hold	13	–	–	﹤0.01%	1472
2016 Q3	$0	Hold	13	–	–	﹤0.01%	1329
2016 Q2	$0	Hold	13	–	–	﹤0.01%	1345
2016 Q1	$0	Hold	13	–	–	﹤0.01%	1571
2015 Q4	$0	Buy	+13	New	+$60	﹤0.01%	1567
2015 Q1	–	Sell	-500	Closed	-$2K	–	525
2014 Q4	$2K	Buy	+500	New	+$2.01K	﹤0.01%	464

AssetMark Inc's AST Position: Q1 2019 in Review

AssetMark Inc sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 13 shares.

AssetMark Inc first reported a position in AST in Q4 2014 and held it in 14 quarters. The position peaked at $2K in Q4 2014. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

AssetMark Inc reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
AssetMark Inc sold 13 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
AssetMark Inc first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 14 quarters.
AssetMark Inc's Asterias Biotherapeutics Inc. Series A position peaked at $2K in Q4 2014.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on AssetMark Inc's 13F filing for Q1 2019, filed 14 May 2019.